Awards and accreditations

Accreditations

1999ISO 9001 quality management system
2002accredited by College of American Pathologists
2003Royal Pharmaceutical Society registration (now General Pharmaceutical Council)
2004first phase 1 unit to get MHRA (Medicines and Healthcare products Regulatory Agency) Manufacturer’s Authorisation [MIA(IMP) No 15140] to import, assemble, package and label non-sterile, sterile and radiopharmaceutical IMPs
2008first phase 1 unit to get Phase 1 Supplementary Accreditation by the MHRA
2010CIR (credit d’impôt recherché) accreditation
2017London Stock Exchange Group designates HMR an Elite Company

*Our accreditations are a tribute to our fierce commitment to quality and safety in everything we do.  We can work with all IMPs and carry out the widest range of phase 1 trials

In addition we have:

  • Environment Agency licence to store and dispose of radiolabelled material
  • Home Office licence to keep controlled drugs
  • Resuscitation Council approval to train staff in immediate and basic life support
  • Resuscitation committee, resuscitation team (24/7 cover) and Resident Medical Officer in compliance with (UK) Resuscitation Council guidelines
  • Thorough knowledge and understanding of the regulations controlling phase 1 trials in the EU: our staff are members of MHRA and National Research Ethics Service committees, and assisted in revising the Association of the British Pharmaceutical Industry guidelines for phase 1 trials

Awards

1995Rubicon Award – New Business of the Year
1998Queen’s Award for Export Achievement*
1999Rubicon Award – Growing Business of the Year
1999Fast Track 100 (100 fastest growing UK companies)
2002Queen’s Award for Enterprise: International Trade*
2004National Training Award for our in-house course leading to a Certificate in Professional and Personal Development
2013Selected by London Stock Exchange Group as one of 1000 Companies to Inspire Britain

*The Queen’s Awards are the highest UK awards for British businesses. The awards are decided on the advice of the Prime Minister after hearing from an advisory committee of leading individuals from industry, commerce, trade unions and government.